Dr. Versalovic is a pediatric pathologist and microbiome scientist who leads research and diagnostic services at Texas Children’s Hospital and Baylor College of Medicine. His work has helped define how the microbiome and metagenomic medicine can be used to diagnose and treat pediatric gastrointestinal and infectious diseases.

Dr. Morrow is an epidemiologist specializing in maternal–infant health, breastfeeding, and the early-life microbiome. She has led major birth cohort studies in term and preterm infants and advises global health organizations on human milk, infant nutrition, and infectious disease.

Dr. Newburg is a leading glycobiologist whose research focuses on the glycobiology of human milk, especially human milk oligosaccharides (HMOs). His work has been central to understanding how HMOs protect infants by supporting beneficial microbes, blocking pathogens, and modulating gut inflammation.

Dr. Taft is a microbiologist studying the development of the infant gut microbiome and how infants acquire both beneficial microbes and antimicrobial resistance genes. Her research spans epidemiology, immunogenetics, and microbiology to better understand early-life colonization and its impact on lifelong health.